METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-κB signaling pathway

Journal of Bone and Mineral Research

Volumn 29, Issue 7, 2014, Pages 1531-1540

  Huang, Jian ^a   Hsu, Yi Hsiang ^b,c   Mo, Chenglin ^a   Abreu, Eduardo ^a   Kiel, Douglas P ^b,c   Bonewald, Lynda F ^a   Brotto, Marco ^a   Karasik, David ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BONE MUSCLE INTERACTIONS; GENETIC RESEARCH; HUMAN ASSOCIATION STUDIES; OSTEOCYTES; SKELETAL MUSCLE

Indexed keywords

CAFFEINE; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLTRANSFERASE; METHYLTRANSFERASE LIKE 21C; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CALCIUM; METTL21C PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MORPHOMETRICS; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; OSTEOCYTE; OSTEOPOROSIS; REAL TIME POLYMERASE CHAIN REACTION; SARCOPENIA; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; DRUG EFFECTS; GENE SILENCING; GENETICS; METABOLISM; MUSCLE; PATHOLOGY; PHENOTYPE; PLEIOTROPY; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE;

ANIMALS; CAFFEINE; CALCIUM; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; DEXAMETHASONE; GENE KNOCKDOWN TECHNIQUES; GENETIC PLEIOTROPY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; METHYLTRANSFERASES; MICE; MUSCLE FIBERS, SKELETAL; MUSCLES; MYOBLASTS; NF-KAPPA B; OSTEOPOROSIS; PHENOTYPE; RNA, SMALL INTERFERING; SARCOPENIA; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

EID: 84903303951     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2200     Document Type: Article

References (68)

1. Bijlsma AY, Meskers CG, Westendorp RG, Maier AB., Chronology of age-related disease definitions: osteoporosis and sarcopenia. Ageing Res Rev. 2012; 11 (2): 320-4.
2. Buford TW, Anton SD, Judge AR, et al. Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev. 2010; 9 (4): 369-83.
3. Brotto M, Abreu EL., Sarcopenia: pharmacology of today and tomorrow. J Pharmacol Exp Ther. 2012; 343 (3): 540-6.
4. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R., The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004; 52 (1): 80-5.
5. Karsenty G, Ferron M., The contribution of bone to whole-organism physiology. Nature. 2012; 481 (7381): 314-20.
6. Pedersen BK., Muscles and their myokines. J Exp Biol. 2011; 214 (Pt 2): 337-46.
7. Hamrick MW., A role for myokines in muscle-bone interactions. Exerc Sport Sci Rev. 2011; 39 (1): 43-7.
8. Dallas SL, Prideaux M, Bonewald LF., The osteocyte: an endocrine cell... and more. Endocr Rev. 2013 Oct; 34 (5): 658-90.
9. Mo C, Romero-Suarez S, Bonewald L, Johnson M, Brotto M., Prostaglandin E2: from clinical applications to its potential role in bone-muscle crosstalk and myogenic differentiation. Recent Pat Biotechnol. 2012; 6 (3): 223-9.
10. Chien KR, Karsenty G., Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell. 2005; 120 (4): 533-44.
11. Jahn K, Lara-Castillo N, Brotto L, et al. Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of beta-catenin. Eur Cell Mater. 2012; 24: 197-209 discussion 209-10.
12. Hsu Y, Chen X, Zillikens C, et al., Multi-phenotype genome-wide association meta-analysis on both lean body mass and BMD identified novel pleiotropic genes that affected skeletal muscle and bone metabolism in European descent Caucasian populations. J Bone Miner Res. 2011; 26 (Suppl 1). Available from: http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid= 7687154e-fea6-4831-b9ab-0f3657dea442.
13. Guo YF, Zhang LS, Liu YJ, et al. Suggestion of GLYAT gene underlying variation of bone size and body lean mass as revealed by a bivariate genome-wide association study. Hum Genet. 2013; 132 (2): 189-99.
14. Gupta M, Cheung CL, Hsu YH, et al. Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations. J Bone Miner Res. 2011; 26 (6): 1261-71.
15. Kernstock S, Davydova E, Jakobsson M, et al. Lysine methylation of VCP by a member of a novel human protein methyltransferase family. Nat Commun. 2012; 3: 1038.
16. Tizioto PC, Decker JE, Taylor JF, et al. Genome scan for meat quality traits in Nelore beef cattle. Physiol Genomics. 2013; 45 (21): 1012-1020.
17. Kimonis VE, Fulchiero E, Vesa J, Watts G., VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta. 2008; 1782: 744-8.
18. Cloutier P, Lavallee-Adam M, Faubert D, Blanchette M, Coulombe B., A newly uncovered group of distantly related lysine methyltransferases preferentially interact with molecular chaperones to regulate their activity. PLoS Genet. 2013; 9 (1): e1003210.
19. Hsu YH, Chen X, Estrada K, et al., Bivariate genome-wide association analysis identifies novel candidate genes for cross-sectional bone geometry and appendicular lean mass: the GEFOS and CHARGE consortia. J Bone Miner Res. 2012; 27 (Suppl 1).
20. Koller DL, Zheng HF, Karasik D, et al. Meta-analysis of genome-wide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women. J Bone Miner Res. 2013; 28 (3): 547-8.
21. Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF., Establishment of an osteocyte-like cell line. MLO-Y4. J Bone Miner Res. 1997; 12 (12): 2014-23.
22. Shen J, Yu WM, Brotto M, et al. Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2 +) homeostasis. Nat Cell Biol. 2009; 11 (6): 769-76.
23. Filigheddu N, Gnocchi VF, Coscia M, et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell. 2007; 18 (3): 986-94.
24. Zhao X, Weisleder N, Thornton A, et al. Compromised store-operated Ca2+ entry in aged skeletal muscle. Aging Cell. 2008; 7 (4): 561-8.
25. Ahuja SS, Zhao S, Bellido T, Plotkin LI, Jimenez F, Bonewald LF., CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology. 2003; 144 (5): 1761-9.
26. Kitase Y, Barragan L, Qing H, et al. Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the beta-catenin and PKA pathways. J Bone Miner Res. 2010; 25 (12): 2657-68.
27. Yaffe D, Saxel O., Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 1977; 270 (5639): 725-7.
28. Thornton AM, Zhao X, Weisleder N, et al. Store-operated Ca(2 +) entry (SOCE) contributes to normal skeletal muscle contractility in young but not in aged skeletal muscle. Aging (Albany NY). 2011; 3 (6): 621-34.
29. Park KH, Brotto L, Lehoang O, Brotto M, Ma J, Zhao X., Ex vivo assessment of contractility, fatigability and alternans in isolated skeletal muscles. J Vis Exp. 2012; (69): e4198.
30. Szulc P, Beck TJ, Marchand F, Delmas PD., Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men-the MINOS study. J Bone Miner Res. 2005; 20 (5): 721-9.
31. Dowthwaite JN, Scerpella TA., Skeletal geometry and indices of bone strength in artistic gymnasts. J Musculoskelet Neuronal Interact. 2009; 9 (4): 198-214.
32. Hamrick M., JMNI special issue: basic science and mechanisms of muscle-bone interactions. J Musculoskelet Neuronal Interact. 2010; 10 (1): 1-2.
33. Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F., The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol. 2010; 205 (3): 201-10.
34. Guo L, Tang K, Quan Z, Zhao Z, Jiang D., Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis. DNA Cell Biol. 2014; 33 (1): 29-39.
35. Petrossian TC, Clarke SG., Uncovering the human methyltransferasome. Mol Cell Proteomics. 2011; 10 (1): M110.000976.
36. Mayer MP, Bukau B., Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci. 2005; 62 (6): 670-84.
37. Li H, Malhotra S, Kumar A., Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl). 2008; 86 (10): 1113-26.
38. Guttridge DC., Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care. 2004; 7 (4): 443-50.
39. Guttridge DC, Albanese C, Reuther JY, Pestell RG., Baldwin AS Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol. 1999; 19 (8): 5785-99.
40. Mitin N, Kudla AJ, Konieczny SF, Taparowsky EJ., Differential effects of Ras signaling through NFkappaB on skeletal myogenesis. Oncogene. 2001; 20 (11): 1276-86.
41. Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM., Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J. 2001; 15 (7): 1169-80.
42. Iwaki K, Chi SH, Dillmann WH, Mestril R., Induction of HSP70 in cultured rat neonatal cardiomyocytes by hypoxia and metabolic stress. Circulation. 1993; 87 (6): 2023-32.
43. Mestril R, Chi SH, Sayen MR, Dillmann WH., Isolation of a novel inducible rat heat-shock protein (HSP70) gene and its expression during ischaemia/hypoxia and heat shock. Biochem J. 1994; 298 (Pt 3): 561-9.
44. Nosek TM, Brotto MA, Essig DA, et al. Functional properties of skeletal muscle from transgenic animals with upregulated heat shock protein 70. Physiol Genomics. 2000; 4 (1): 25-33.
45. Broer L, Demerath EW, Garcia ME, et al. Association of heat shock proteins with all-cause mortality. Age (Dordr). 2013; 35 (4): 1367-76.
46. Porter GA Jr, Makuck RF, Rivkees SA., Reduction in intracellular calcium levels inhibits myoblast differentiation. J Biol Chem. 2002; 277 (32): 28942-7.
47. Guzhova IV, Darieva ZA, Melo AR, Margulis BA., Major stress protein Hsp70 interacts with NF-kB regulatory complex in human T-lymphoma cells. Cell Stress Chaperones. 1997; 2 (2): 132-9.
48. Van Molle W, Wielockx B, Mahieu T, et al. HSP70 protects against TNF-induced lethal inflammatory shock. Immunity. 2002; 16 (5): 685-95.
49. Ran R, Lu A, Zhang L, et al. Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling. Genes Dev. 2004; 18 (12): 1466-81.
50. Chen H, Wu Y, Zhang Y, et al. Hsp70 inhibits lipopolysaccharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitination. FEBS Lett. 2006; 580 (13): 3145-52.
51. Senf SM, Dodd SL, McClung JM, Judge AR., Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J. 2008; 22 (11): 3836-45.
52. Jin HS, Lee DH, Kim DH, Chung JH, Lee SJ, Lee TH., cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation. Cancer Res. 2009; 69 (5): 1782-91.
53. Sarkar SA, Kutlu B, Velmurugan K, et al. Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line. Diabetologia. 2009; 52 (6): 1092-101.
54. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr., NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 1998; 281 (5383): 1680-3.
55. Genin P, Algarte M, Roof P, Lin R, Hiscott J., Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J Immunol. 2000; 164 (10): 5352-61.
56. Corti S, Salani S, Del Bo R, et al. Chemotactic factors enhance myogenic cell migration across an endothelial monolayer. Exp Cell Res. 2001; 268 (1): 36-44.
57. Zhang CY, Fu WJ, Xi H, et al. [Busulfan, cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma]. Zhonghua Xue Ye Xue Za Zhi. 2013; 34 (4): 313-6. In Chinese.
58. De Paepe B, Creus KK, Martin JJ, De Bleecker JL., Upregulation of chemokines and their receptors in Duchenne muscular dystrophy: potential for attenuation of myofiber necrosis. Muscle Nerve. 2012; 46 (6): 917-25.
59. Zhan M, Jin B, Chen SE, Reecy JM, Li YP., TACE release of TNF-alpha mediates mechanotransduction-induced activation of p38 MAPK and myogenesis. J Cell Sci. 2007; 120 (Pt 4): 692-701.
60. Chen SE, Jin B, Li YP., TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol. 2007; 292 (5): C1660-71.
61. Langen RC, Schols AM, Kelders MC, Van Der Velden JL, Wouters EF, Janssen-Heininger YM., Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol. 2002; 283 (3): C714-21.
62. Mahoney DJ, Cheung HH, Mrad RL, et al. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci U S A. 2008; 105 (33): 11778-83.
63. Tolosa L, Morla M, Iglesias A, Busquets X, Llado J, Olmos G., IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity. Cell Signal. 2005; 17 (11): 1333-42.
64. O'Brien CA, Jia D, Plotkin LI, et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology. 2004; 145 (4): 1835-41.
65. Oostlander AE, Bravenboer N, Sohl E, et al. Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease. Gastroenterology. 2011; 140 (1): 116-23.
66. Kogianni G, Mann V, Noble BS., Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res. 2008; 23 (6): 915-27.
67. Abu-Amer Y., NF-kB Signalling and Bone Resorption. Osteoporos Int. 2013; 24 (9): 2377-86.
68. Xiong J, O'Brien CA., Osteocyte RANKL: new insights into the control of bone remodeling. J Bone Miner Res. 2012; 27 (3): 499-505.